muscular invasive bladder cancer (MIBC) | |
MIBC - NA - PDL1 positive | |
immune chekpoint inhibitors | |
anti-PD-(L)1 | |
nivolumab based treatment | |
nivolumab alone | CheckMate 274 ... |
Study type:
delta: difference in rate or median (if available)
- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy -